My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Board of Rane (Madras) declares interim dividend
Jan 23,2017

Rane (Madras) announced that the Board of Directors of the Company at its meeting held on 23 January 2017, inter alia, has declared an interim dividend of Rs. 2/- per equity share of Rs. 10/- each.

Powered by Capital Market - Live News

United Spirits leads gainers in A group
Jan 23,2017

United Spirits jumped 4.18% to Rs 2,164.95 at 13:19 IST after net profit jumped 296.72% to Rs 147.70 crore on 6.77% growth in total income to Rs 7117.79 crore in Q3 December 2016 over Q3 December 2015. The result was announced on Saturday, 21 January 2017. The stock topped the gainers in the BSEs A group. On the BSE, 1.63 lakh shares were traded on the counter so far as against the average daily volumes of 79,000 shares in the past two weeks.

Hindalco Industries surged 3.27% at Rs 177.05. The stock was second biggest gainer in A group. On the BSE, 10.51 lakh shares were traded on the counter so far as against the average daily volumes of 14.12 lakh shares in the past two weeks.

SREI Infrastructure Finance advanced 3.26% to Rs 85.60. The stock was third biggest gainer in A group. On the BSE, 93,000 shares were traded on the counter so far as against the average daily volumes of 2.80 lakh shares in the past two weeks.

IL&FS Transportation Networks gained 3.17% at Rs 112.30. The stock was fourth biggest gainer in A group. On the BSE, 86,000 shares were traded on the counter so far as against the average daily volumes of 1.97 lakh shares in the past two weeks.

BEML rose 2.96% to Rs 1,192.95. The stock was fifth biggest gainer in A group. On the BSE, 88,000 shares were traded on the counter so far as against the average daily volumes of 2.50 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Volumes jump at JK Agri Genetics counter
Jan 23,2017

JK Agri Genetics clocked volume of 1.72 lakh shares by 12:30 IST on BSE, a 266.33-times surge over two-week average daily volume of 647 shares. The stock fell 5.05% to Rs 545.

Gujarat Fluorochemicals notched up volume of 1.25 lakh shares, a 82.38-fold surge over two-week average daily volume of 1,519 shares. The stock rose 1.31% to Rs 481.05.

Deepak Fertilisers & Petrochemicals Corporation saw volume of 12.08 lakh shares, a 16.14-fold surge over two-week average daily volume of 75,000 shares. The stock rose 2.75% to Rs 269.25.

Hero MotoCorp clocked volume of 1.10 lakh shares, a 5.80-fold surge over two-week average daily volume of 19,000 shares. The stock rose 0.64% to Rs 3,076.10.

HOV Services saw volume of 4.45 lakh shares, a 4.30-fold rise over two-week average daily volume of 1.03 lakh shares. The stock rose 15.82% to Rs 159.60.

Powered by Capital Market - Live News

Rane Brake Lining advances after reporting decent Q3 results
Jan 23,2017

The result was announced after market hours on Friday, 20 January 2017.

Meanwhile, the BSE Sensex was up 83.51 points, or 0.31%, to 27,118.01.

On the BSE, 5,552 shares were traded on the counter so far as against the average daily volumes of 12,770 shares in the past one quarter. The stock had hit a high of Rs 1,015 and a low of Rs 978.45 so far during the day.

The stock had hit a record high of Rs 1,399 on 15 September 2016 and a 52-week low of Rs 287.20 on 21 January 2016. The stock had underperformed the market over the past one month till 20 January 2017, sliding 0.29% compared with the Sensexs 2.76% rise. The scrip had also underperformed the market over the past one quarter declining 23.42% as against the Sensexs 3.89% fall.

The small-cap company has equity capital of Rs 7.91 crore. Face value per share is Rs 10.

Rane Brake Linings earnings before interest, tax, depreciation and amortization (EBITDA) increased by 7% to Rs 17.66 crore in Q3 December 2016 over Q3 December 2015.

EBITDA margin increased a tad to 14.8% in Q3 December 2016 as against 14.7% in Q3 December 2015.

The company said that it witnessed strong demand from Indian original equipment manufacturers (OEM) customers predominantly in the passenger vehicle and commercial vehicle segment. The Indian aftermarket business was affected due to demonetization, however, disc pads products maintained its growth momentum.

It witnessed a demand drop in the rail segment while international aftermarkets recorded flat performance. The effect of adverse currency movement and unfavorable product mix was offset by continued cost reduction and operating measures, it added.

The board has declared interim dividend of Rs 6 per share for the year ending 31 March 2017 (FY 2017). The record date of interim dividend is 2 February 2017.

Rane Brake Lining manufactures friction material products such as brake linings, disc pads, clutch facings, clutch buttons, brake shoes and railway brake blocks.

Powered by Capital Market - Live News

Suven Life Sciences gains after securing product patent in Australia
Jan 23,2017

The announcement was made during trading hours today, 23 January 2017.

Meanwhile, the BSE Sensex was up 41.68 points, or 0.15%, to 27,076.18.

On the BSE, so far 38,000 shares were traded in the counter, compared with average daily volumes of 56,949 shares in the past one quarter. The stock had hit a high of Rs 178.40 and a low of Rs 170.70 so far during the day.

The stock hit a 52-week high of Rs 228.50 on 30 May 2016. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past 30 days till 20 January 2017, rising 2.62% compared with the 4.06% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 14.49% as against Sensexs 3.71% decline.

The small-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced that the grant of one product patent from Australia corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and the patent is valid through 2033.

The granted claims of the patents are from the mechanism of action include the class of selective 5HT4 compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of twenty five (25) granted patents from Australia. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.

Suven Life Sciences net profit rose 5.2% to Rs 26.56 crore on 1.2% decline in net sales to Rs 115.55 crore in Q2 September 2016 over Q2 September 2015.

Suven Life Science is a bio-pharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products.

Powered by Capital Market - Live News

Suzlon Energy secured repeat order of 50.40 MW
Jan 23,2017

Suzlon Energy announced its repeat order win of 50.40 MW from a leading power utility. The project consists of 24 units of S97 120 m hybrid tower with rated capacity of 2.1 MW. Located in Kutch, Gujarat, the project will be completed by March 2017.

Powered by Capital Market - Live News

Suzlon Energy secured repeat order of 50.40 MW
Jan 23,2017

Suzlon Energy announced its repeat order win of 50.40 MW from a leading power utility. The project consists of 24 units of S97 120 m hybrid tower with rated capacity of 2.1 MW. Located in Kutch, Gujarat, the project will be completed by March 2017.

Powered by Capital Market - Live News

Citadel Realty & Developers to consider December quarter results
Jan 23,2017

Citadel Realty & Developers announced that a Meeting of Board of Directors of the Company is scheduled to be held on 30 January 2017, inter alia, to take on record the Un-audited Financial Results, for the year (F. Y. 2016 - 2017) ended on 31 December 2016.

Powered by Capital Market - Live News

Board of Hem Holdings & Trading to consider December quarter results
Jan 23,2017

Hem Holdings & Trading announced that a Meeting of the Board of Directors of the Company will be held on 10 February 2017 to consider and adopt Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended on 31 December 2016.

Powered by Capital Market - Live News

D-Link India jumps after strong Q3 numbers
Jan 23,2017

The result was announced on Saturday, 21 January 2017.

Meanwhile, the BSE Sensex was up 97.71 points, or 0.36%, to 27,132.21.

On the BSE, so far 1.76 lakh shares were traded in the counter, compared with average daily volumes of 1.33 lakh shares in the past one quarter. The stock had hit a high of Rs 123.90 and a low of Rs 117.50 so far during the day.

The stock hit a 52-week high of Rs 145.50 on 19 February 2016. The stock hit a 52-week low of Rs 75.25 on 21 September 2016. The stock had outperformed the market over the past 30 days till 20 January 2017, rising 4.78% compared with the 4.06% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 22.86% as against Sensexs 3.71% decline.

The small-cap company has equity capital of Rs 7.10 crore. Face value per share is Rs 2.

D-Link India is engaged in the design, manufacture and marketing of advanced networking, broadband, digital, voice and data communications solutions.

Powered by Capital Market - Live News

Unichem Lab moves higher after good Q3 outcome
Jan 23,2017

The result was announced on Saturday, 21 January 2017.

Meanwhile, the S&P BSE Sensex was up 102.10 points or 0.38% at 27,136.60.

On the BSE, 6,713 shares were traded on the counter so far as against the average daily volumes of 12,805 shares in the past one quarter. The stock had hit a high of Rs 279 and a low of Rs 273 so far during the day.

The stock had hit a 52-week high of Rs 319.90 on 20 October 2016 and a 52-week low of Rs 189 on 11 February 2016. The stock had underperformed the market over the past one month till 20 January 2017, advancing 0.65% compared with the Sensexs 2.76% rise. The scrip had also underperformed the market over the past one quarter, declining 11.52% as against the Sensexs 3.89% fall.

The small-cap company has equity capital of Rs 18.17 crore. Face value per share is Rs 2.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.

Powered by Capital Market - Live News

Agenda for board meeting of Himalya International
Jan 23,2017

Himalya International announced that the Board of Directors will meet on 28 January 2017 to consider and approved the following -

To consider unaudited financial results for the quarter ended 31 December 2016.

To consider progress and further steps to be taken for the assets reconstruction plan under the company scheme of demerger.

To review pending export orders and further development of products for exports as per customers requirements.

To consider revival of marketing all products within the country and discuss the strategy to review Himalya Fresh Brand for all Companys products.

Powered by Capital Market - Live News

Board of Divis Laboratories to consider Q3 results
Jan 23,2017

Divis Laboratories announced that a meeting of Board of Directors of the Company is scheduled to be held on 04 February 2017, inter alia, to consider and approve, the un-audited financial results for the quarter and nine months ended 31 December 2016(Q3).

Powered by Capital Market - Live News

Bharat Petroleum Corporation to consider Q3 results
Jan 23,2017

Bharat Petroleum Corporation announced that a meeting of the Board of Directors of the Company will be held on 09 February 2017, inter alia, to take on record the Unaudited financial Results (Provisional) of the Company for the quarter ended 31 December 2016(Q3).

Powered by Capital Market - Live News

3M India to consider Q3 and 9M results
Jan 23,2017

3M India announced that a meeting of the Board of Directors will be held on 09 February 2016, inter alia, to consider and approve the unaudited financial results for the quarter and nine months ended 31 December 2016.

Powered by Capital Market - Live News